Literature DB >> 16442251

Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration.

Hartmut Hahn1, Bernd Kammerer, Andre DiMauro, Alec N Salt, Stefan K Plontke.   

Abstract

Before new drugs for the treatment of inner ear disorders can be studied in controlled clinical trials, it is important that their pharmacokinetics be established in inner ear fluids. Microdialysis allows drug levels to be measured in perilymph without the volume disturbances and potential cerebrospinal fluid contamination associated with fluid sampling. The aims of this study were to show: (i) that despite low recovery rates from miniature dialysis probes, significant amounts of drug are removed from small fluid compartments, (ii) that dialysis sampling artifacts can be accounted for using computer simulations and (iii) that microdialysis allows quantification of the entry rates through the round window membrane (RWM) into scala tympani (ST). Initial experiments used microdialysis probes in small compartments in vitro containing sodium fluorescein. Stable concentrations were observed in large compartments (1000 microl) but significant concentration declines were observed in smaller compartments (100, 10 and 5.6 microl) comparable to the size of the inner ear. Computer simulations of these experiments closely approximated the experimental data. In in vivo experiments, sodium fluorescein 10 mg/ml and dexamethasone-dihydrogen-phosphate disodium salt 8 mg/ml were simultaneously applied to the RWM of guinea pigs. Perilymph concentration in the basal turn of ST was monitored using microdialysis. The fluorescein concentration reached after 200 min application (585+/-527 microg/ml) was approximately twice that of dexamethasone phosphate (291+/-369 microg/ml). Substantial variation in concentrations was found between animals by approximately a factor of 34 for fluorescein and at least 41 for dexamethasone phosphate. This is, to a large extent, thought to be the result of the RWM permeability varying in different animals. It was not caused by substance analysis variations, because two different analytic methods were used and the concentration ratio between the two substances remained nearly constant across the experiments and because differences were apparent for the repeated samples obtained in each animal. Interpretation of the results using computer simulations allowed RWM permeability to be quantified. It also demonstrated, however, that cochlear clearance values could not be reliably obtained with microdialysis because of the significant contribution of dialysis to clearance. The observed interanimal variation, e.g., in RWM permeability, is likely to be clinically relevant to the local application of drugs in patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442251      PMCID: PMC1751486          DOI: 10.1016/j.heares.2005.12.001

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  44 in total

1.  Perilymphatic concentration of gentamicin administered intratympanically in guinea pigs.

Authors:  T Hibi; T Suzuki; T Nakashima
Journal:  Acta Otolaryngol       Date:  2001-04       Impact factor: 1.494

2.  Treatment of vestibular disorders.

Authors:  A Itoh; E Sakata
Journal:  Acta Otolaryngol Suppl       Date:  1991

3.  Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation.

Authors:  S S Chandrasekhar
Journal:  Otol Neurotol       Date:  2001-01       Impact factor: 2.311

4.  Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents.

Authors:  S S Chandrasekhar; R Y Rubinstein; J A Kwartler; M Gatz; P E Connelly; E Huang; S Baredes
Journal:  Otolaryngol Head Neck Surg       Date:  2000-04       Impact factor: 3.497

5.  The glutamate receptor agonist, AMPA, induces acetylcholine release in guinea pig cochlea; a microdialysis study.

Authors:  N Hoya; K Ogawa; Y Inoue; Y Takiguchi; J Kanzaki
Journal:  Neurosci Lett       Date:  2001-10-05       Impact factor: 3.046

6.  [Permeability of the round window membrane for prednisolone-21-hydrogen succinate. Prednisolone content of the perilymph after local administration vs. systemic injection].

Authors:  G Bachmann; J Su; C Zumegen; C Wittekindt; O Michel
Journal:  HNO       Date:  2001-07       Impact factor: 1.284

Review 7.  Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Ménière's disease.

Authors:  J J Shea; X Ge
Journal:  Otolaryngol Clin North Am       Date:  1996-04       Impact factor: 3.346

8.  Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere's disease.

Authors:  L Sennaroglu; G Sennaroglu; B Gursel; F M Dini
Journal:  Otolaryngol Head Neck Surg       Date:  2001-11       Impact factor: 3.497

9.  Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.

Authors:  Haralampos Gouveris; Oksana Selivanova; Wolf Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-04-29       Impact factor: 2.503

10.  Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment.

Authors:  Ho Guan-Min Ho; Hung-Ching Lin; Min-Tsan Shu; Cheng-Chien Yang; Hsun-Tien Tsai
Journal:  Laryngoscope       Date:  2004-07       Impact factor: 3.325

View more
  26 in total

1.  Intratympanic dexamethasone perfusion versus injection for treatment of refractory sudden sensorineural hearing loss.

Authors:  Lihua Li; Jihao Ren; Tuanfang Yin; Wei Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-06       Impact factor: 2.503

2.  Simulation of application strategies for local drug delivery to the inner ear.

Authors:  Stefan K Plontke; Alec N Salt
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2006-10-26       Impact factor: 1.538

3.  In-vitro perforation of the round window membrane via direct 3-D printed microneedles.

Authors:  Aykut Aksit; Daniel N Arteaga; Miguel Arriaga; Xun Wang; Hirobumi Watanabe; Karen E Kasza; Anil K Lalwani; Jeffrey W Kysar
Journal:  Biomed Microdevices       Date:  2018-06-08       Impact factor: 2.838

Review 4.  Principles of local drug delivery to the inner ear.

Authors:  Alec N Salt; Stefan K Plontke
Journal:  Audiol Neurootol       Date:  2009-11-16       Impact factor: 1.854

5.  Controlled release dexamethasone implants in the round window niche for salvage treatment of idiopathic sudden sensorineural hearing loss.

Authors:  Stefan K Plontke; Alexander Glien; Torsten Rahne; Karsten Mäder; Alec N Salt
Journal:  Otol Neurotol       Date:  2014-08       Impact factor: 2.311

6.  [Reduction of permanent hearing loss by local glucocorticoid application : Guinea pigs with acute acoustic trauma. German version].

Authors:  M Müller; M Tisch; H Maier; H Löwenheim
Journal:  HNO       Date:  2016-11       Impact factor: 1.284

7.  Rapid clearance of methylprednisolone after intratympanic application in humans. Comment on: Bird PA, Begg EJ, Zhang M, et al. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 2007;28:1124-30.

Authors:  Stefan K Plontke; Anthony A Mikulec; Alec N Salt
Journal:  Otol Neurotol       Date:  2008-08       Impact factor: 2.311

8.  Microperforations significantly enhance diffusion across round window membrane.

Authors:  Catherine M Kelso; Hirobumi Watanabe; Joseph M Wazen; Tizian Bucher; Zhen J Qian; Elizabeth S Olson; Jeffrey W Kysar; Anil K Lalwani
Journal:  Otol Neurotol       Date:  2015-04       Impact factor: 2.311

9.  Dexamethasone concentration gradients along scala tympani after application to the round window membrane.

Authors:  Stefan K Plontke; Thorsten Biegner; Bernd Kammerer; Ursular Delabar; Alec N Salt
Journal:  Otol Neurotol       Date:  2008-04       Impact factor: 2.311

10.  Perilymph pharmacokinetics of markers and dexamethasone applied and sampled at the lateral semi-circular canal.

Authors:  Alec N Salt; Jared J Hartsock; Ruth M Gill; Fabrice Piu; Stefan K Plontke
Journal:  J Assoc Res Otolaryngol       Date:  2012-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.